
Chinese General Practice ›› 2021, Vol. 24 ›› Issue (6): 684-689.DOI: 10.12114/j.issn.1007-9572.2020.00.614
Special Issue: 衰弱最新文章合辑; 胰腺炎最新文章合辑; 呼吸疾病文章合辑; 营养最新文章合辑
• Monographic Research • Previous Articles Next Articles
Published:2021-02-20
Online:2021-02-20
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2020.00.614
| [1]CAPISTRANO S J,VAN REYK D,CHEN H,et al.Evidence of biomass smoke exposure as a causative factor for the development of COPD[J].Toxics,2017,5(4):E36.DOI:10.3390/toxics5040036. [2]张春丽,张宏英.慢性阻塞性肺疾病病人肺康复卫生经济学评价研究现状[J].全科护理,2019,17(30):3745-3747.DOI:10.12104/j.issn.1674-4748.2019.30.005. ZHANG C L,ZHANG H Y.Status quo of economic evaluation of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease[J].Chinese General Practice Nursing,2019,17(30):3745-3747.DOI:10.12104/j.issn.1674-4748.2019.30.005. [3]侯晓琳,姚倩.衰弱在慢性阻塞性肺疾病中的研究进展[J].现代临床医学,2019,45(3):218-222.DOI:10.11851/j.issn.1673-1557.2019.03.022. [4]TICINESI A,NOUVENNE A,CERUNDOLO N,et al.Gut microbiota,muscle mass and function in aging:a focus on physical frailty and sarcopenia[J].Nutrients,2019,11(7):E1633.DOI:10.3390/nu11071633. [5]TICINESI A,LAURETANI F,MILANI C,et al.Aging gut microbiota at the cross-road between nutrition,physical frailty,and sarcopenia:is there a gut-muscle axis?[J].Nutrients,2017,9(12):E1303.DOI:10.3390/nu9121303. [6]FINLAY B B,PETTERSSON S,MELBY M K,et al.The microbiome mediates environmental effects on aging[J].Bioessays,2019,41(10):e1800257.DOI:10.1002/bies.201800257. [7]VAN DE WOUW M,SCHELLEKENS H,DINAN T G,et al.Microbiota-gut-brain axis:modulator of host metabolism and appetite[J].J Nutr,2017,147(5):727-745.DOI:10.3945/jn.116.240481. [8]SAINT-GEORGES-CHAUMET Y,EDEAS M.Microbiota-mitochondria inter-talk:consequence for microbiota-host interaction[J].Pathog Dis,2016,74(1):ftv096.DOI:10.1093/femspd/ftv096. [9]HÉNIQUE C,MANSOURI A,VAVROVA E,et al.Increasing mitochondrial muscle fatty acid oxidation induces skeletal muscle remodeling toward an oxidative phenotype[J].Faseb J,2015,29(6):2473-2483.DOI:10.1096/fj.14-257717. [10]SACHS S,ZARINI S,KAHN D E,et al.Intermuscular adipose tissue directly modulates skeletal muscle insulin sensitivity in humans[J].Am J Physiol Endocrinol Metab,2019,316(5):E866-879.DOI:10.1152/ajpendo.00243.2018. [11]SPROOTEN R T M,LENAERTS K,BRAEKEN D C W,et al.Increased small intestinal permeability during severe acute exacerbations of COPD[J].Respiration,2018,95(5):334-342.DOI:10.1159/000485935. [12]O'DONNELL D E,NEDER J A,ELBEHAIRY A F.Physiological impairment in mild COPD[J].Respirology,2016,21(2):211-223.DOI:10.1111/resp.12619. [13]CHUNG K F.Inflammatory mediators in chronic obstructive pulmonary disease[J].Curr Drug Targets Inflamm Allergy,2005,4(6):619-625.DOI:10.2174/156801005774912806. [14]SINDEN N J,STOCKLEY R A.Systemic inflammation and comorbidity in COPD:a result of 'overspill' of inflammatory mediators from the lungs? Review of the evidence[J].Thorax,2010,65(10):930-936.DOI:10.1136/thx.2009.130260. [15]GRECO E A,PIETSCHMANN P,MIGLIACCIO S.Osteoporosis and sarcopenia increase frailty syndrome in the elderly[J].Front Endocrinol (Lausanne),2019,10:255.DOI:10.3389/fendo.2019.00255. [16]VLACHAKIS D,ZACHARAKI E I,TSIAMAKI E,et al.Insights into the molecular mechanisms of stress and inflammation in ageing and frailty of the elderly[J].J Mol Biochem,2017,6:41-44. [17]DERBRÉ F,GRATAS-DELAMARCHE A,GÓMEZ-CABRERA M C,et al.Inactivity-induced oxidative stress:a central role in age-related sarcopenia?[J].Eur J Sport Sci,2014,14(Suppl 1):S98-108.DOI:10.1080/17461391.2011.654268. [18]SOYSAL P,ISIK A T,CARVALHO A F,et al.Oxidative stress and frailty:a systematic review and synthesis of the best evidence[J].Maturitas,2017,99:66-72.DOI:10.1016/j.maturitas.2017.01.006. [19]SINGH S,VERMA S K,KUMAR S,et al.Evaluation of oxidative stress and antioxidant status in chronic obstructive pulmonary disease[J].Scand J Immunol,2017,85(2):130-137.DOI:10.1111/sji.12498. [20]TAVILANI H,NADI E,KARIMI J,et al.Oxidative stress in COPD patients,smokers,and non-smokers[J].Respir Care,2012,57(12):2090-2094.DOI:10.4187/respcare.01809. [21]GEA J,PASCUAL S,CASADEVALL C,et al.Muscle dysfunction in chronic obstructive pulmonary disease:update on causes and biological findings[J].J Thorac Dis,2015,7(10):E418-438.DOI:10.3978/j.issn.2072-1439.2015.08.04. [22]樊申元,靳二辉.PI3K/Akt/mTOR信号通路对自然衰老小鼠骨骼肌自噬的影响及不同运动方式的调控[J].沈阳体育学院学报,2016,35(1):82-86,92.DOI:10.3969/j.issn.1004-0560.2016.01.014. FAN S Y,JIN E H.Effect of different exercise modes on autophagy of muscles in aging female mice through the PI3K/AKT/mTOR pathway[J].Journal of Shenyang Sport University,2016,35(1):82-86,92.DOI:10.3969/j.issn.1004-0560.2016.01.014. [23]王丽,丁树哲.细胞生长中的PI3K/Akt/mTOR信号通路及其与运动的关系[J].体育科学,2007,27(5):77-82.DOI:10.3969/j.issn.1000-677X.2007.05.013. WANG L,DING S Z.PI3K/Akt/mTOR signaling pathway in the process of cell growth and its relation with exercise[J].China Sport Science,2007,27(5):77-82.DOI:10.3969/j.issn.1000-677X.2007.05.013. [24]杨湘怡,陶润知,聂亚雄.mTOR依赖的自噬通路与神经变性疾病[J].中南医学科学杂志,2014,42(2):191-195,214. [25]PATEL M S,LEE J,BAZ M,et al.Growth differentiation factor-15 is associated with muscle mass in chronic obstructive pulmonary disease and promotes muscle wasting in vivo[J].J Cachexia Sarcopenia Muscle,2016,7(4):436-448.DOI:10.1002/jcsm.12096. [26]TANAKA R,SUGIURA H,YAMADA M,et al.Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease[J].Int J Chron Obstruct Pulmon Dis,2018,13:1333-1342.DOI:10.2147/COPD.S157035. [27]DAVIS L M,MARTÍNEZ I,WALTER J,et al.Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans[J].PLoS One,2011,6(9):e25200.DOI:10.1371/journal.pone.0025200. [28]BUIGUES C,FERNÁNDEZ-GARRIDO J,PRUIMBOOM L,et al.Effect of a prebiotic formulation on frailty syndrome:a randomized,double-blind clinical trial[J].Int J Mol Sci,2016,17(6):E932.DOI:10.3390/ijms17060932. [29]CAULI O,FERNANDEZ-GARRIDO J,BUIGUES C,et al.Beneficial effects of prebiotic formulation in frailty syndrome in a randomized and placebo-controlled trial:role of cytokines[J].Ann Nutr Metab,2019.DOI:10.1159/000496759. [30]GHOSH T S,RAMPELLI S,JEFFERY I B,et al.Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status:the NU-AGE 1-year dietary intervention across five European countries[J].Gut,2020,69(7):1218-1228.DOI:10.1136/gutjnl-2019-319654. [31]KIM D,WON C W,PARK Y.Association between erythrocyte levels of n-3 polyunsaturated fatty acids and risk of frailty in community-dwelling older adults:the Korean Frailty and Aging Cohort Study[J].J Gerontol A Biol Sci Med Sci,2020:glaa042.DOI:10.1093/gerona/glaa042. [32]PANSARASA O,PISTONO C,DAVIN A,et al.Altered immune system in frailty:genetics and diet may influence inflammation[J].Ageing Res Rev,2019,54:100935.DOI:10.1016/j.arr.2019.100935. [33]弓剑,晓敏.多不饱和脂肪酸代谢及其对炎症的调节[J].动物营养学报,2017,29(1):1-7.DOI:10.3969/j.issn.1006-267x.2017.01.001. GONG J,XIAO M.The metabolism of polyunsaturated fatty acids and its regulation to inflammation[J].Acta Zoonutrimenta Sinica,2017,29(1):1-7.DOI:10.3969/j.issn.1006-267x.2017.01.001. [34]ATLANTIS E,COCHRANE B.The association of dietary intake and supplementation of specific polyunsaturated fatty acids with inflammation and functional capacity in chronic obstructive pulmonary disease:a systematic review[J].Int J Evid Based Healthc,2016,14(2):53-63.DOI:10.1097/XEB.0000000000000056. [35]DE BATLLE J,SAULEDA J,BALCELLS E,et al.Association between Ω3 and Ω6 fatty acid intakes and serum inflammatory markers in COPD[J].J Nutr Biochem,2012,23(7):817-821.DOI:10.1016/j.jnutbio.2011.04.005. [36]BROEKHUIZEN R,WOUTERS E F,CREUTZBERG E C,et al.Polyunsaturated fatty acids improve exercise capacity in chronic obstructive pulmonary disease[J].Thorax,2005,60(5):376-382.DOI:10.1136/thx.2004.030858. [37]DENT E,MORLEY J E,CRUZ-JENTOFT A J,et al.Physical frailty:ICFSR international clinical practice guidelines for identification and management[J].J Nutr Health Aging,2019,23(9):771-787.DOI:10.1007/s12603-019-1273-z. [38]MALCOMSON F C,MATHERS J C.Nutrition and ageing[J].Subcell Biochem,2018,90:373-424.DOI:10.1007/978-981-13-2835-0_13. [39]DRAGANIDIS D,KARAGOUNIS L G,ATHANAILIDIS I,et al.Inflammaging and skeletal muscle:can protein intake make a difference?[J].J Nutr,2016,146(10):1940-1952.DOI:10.3945/jn.116.230912. [40]袁仲飞,刘先燕.早期营养支持对维持性血液透析患者氧化应激状态和生活质量的影响[J].中国现代医生,2020,58(6):97-100. YUAN Z F,LIU X Y.Impacts of early nutritional support on oxidative stress and quality of life in patients on maintenance hemodialysis[J].China Modern Doctor,2020,58(6):97-100. [41]DEUTZ N E,BAUER J M,BARAZZONI R,et al.Protein intake and exercise for optimal muscle function with aging:recommendations from the ESPEN Expert Group[J].Clin Nutr,2014,33(6):929-936.DOI:10.1016/j.clnu.2014.04.007. [42]AZZOLINO D,AROSIO B,MARZETTI E,et al.Nutritional status as a mediator of fatigue and its underlying mechanisms in older people[J].Nutrients,2020,12(2):E444.DOI:10.3390/nu12020444. [43]ST-ONGE M P,MIKIC A,PIETROLUNGO C E.Effects of diet on sleep quality[J].Adv Nutr,2016,7(5):938-949.DOI:10.3945/an.116.012336. [44]TANAKA E,YATSUYA H,UEMURA M,et al.Associations of protein,fat,and carbohydrate intakes with insomnia symptoms among middle-aged Japanese workers[J].J Epidemiol,2013,23(2):132-138.DOI:10.2188/jea.je20120101. |
| [1] | CHEN Dian, LONG Huanyu, CHU Lanhe, JIANG Yixia, GUO Wanjin, NIU Yang, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2026 Report [J]. Chinese General Practice, 2026, 29(21): 2913-2932. |
| [2] | ZHANG Wenbo, WANG Junlong, ZHANG Yuping, JIANG Shuai, WANG Huaqi. The Risk of Pre-COPD Populations Progressing to COPD under Different Criteria: a Meta-analysis [J]. Chinese General Practice, 2026, 29(19): 2735-2743. |
| [3] | ZHAO Xuedan, AI Yue, JIN Guoen, JIA Guoqiang. The New Research Progress of Non-infectious Lung Diseases in High Altitude Areas [J]. Chinese General Practice, 2026, 29(14): 1931-1938. |
| [4] | YANG Fangting, XU Junfeng, YANG Qin, MA Yingzhi, ZHOU Ling, XIAO Jiangqin. Analysis of the Current Situation and Influencing Factors of Intolerance of Uncertainty in AECOPD Patients under the Perspective of Health Ecology [J]. Chinese General Practice, 2026, 29(11): 1434-1440. |
| [5] | SONG Lu, WANG Liye, XIU Chunxia, FENG Baojing, FENG Liping, GAO Yansong, LI Meng, DAI Yan. The Correlation Study of Pulmonary Function and Blood Pressure Variability in Patients with Chronic Obstructive Pulmonary Disease and Hypertension [J]. Chinese General Practice, 2026, 29(10): 1311-1315. |
| [6] | TIAN Ying, PAN Dianzhu. Analysis of Related Factors of Renal Function Impairment in AECOPD Patients [J]. Chinese General Practice, 2026, 29(07): 885-892. |
| [7] | CHEN Chuping, LIU Lidi, YANG Ziyu, ZHANG Peng, ZHANG Rui, YUAN Bo, SHEN Can, YANG Rong, LI Dongze, LIAO Xiaoyang, LEI Yi. Implications for the Management of Chronic Obstructive Pulmonary Disease Patients Based on the Italian Consensus in 2024: Triple Inhalation Therapy in Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2026, 29(06): 688-692. |
| [8] | Guideline Working Group of Integrated Traditional Chinese and Western Medicine Management for Chronic Obstructive Pulmonary Disease. Guidelines of Integrated Traditional Chinese and Western Medicine for Diagnosis and Treatment of Chronic Obstructive Pulmonary Disease (2025 Edition) [J]. Chinese General Practice, 2026, 29(04): 409-422. |
| [9] | CHEN Xueqin, WANG Shihong, LAI Fengxia, ZHANG Jingjing, CHEN Hao, KONG Danli, DING Yuanlin. Study on Trend Analysis and Forecast of Incidence, Disease and Mortality of Chronic Obstructive Pulmonary Disease in China, 1990-2021 [J]. Chinese General Practice, 2026, 29(02): 264-272. |
| [10] | SHAO Jiachen, LI Shunping, YANG Ting, ZHANG Chunyu, LU Liyong, YUAN Jiaqi. A Review of Discrete Choice Experiment in Treatment and Device Preferences for Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2025, 28(36): 4648-4654. |
| [11] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
| [12] | JING Chenchen, WANG Yanru, WANG Shujuan, XU Huihui, XING Qing. Study on the Relationship between Respiratory Drive Index and Oxygenation after Sputum Aspiration in Patients with Noninvasive Mechanical Ventilation [J]. Chinese General Practice, 2025, 28(20): 2516-2522. |
| [13] | JIN Feng, LI Wangling, XIE Fei. Case Sharing of Closed-loop Management Based on the Prevention and Treatment Platform for Chronic Obstructive Pulmonary Disease [J]. Chinese General Practice, 2025, 28(16): 2059-2064. |
| [14] | CHEN Dian, LONG Huanyu, ZHANG Congxi, CHU Lanhe, LI Shurun, CHEN Yahong. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2025 Report [J]. Chinese General Practice, 2025, 28(16): 1937-1949. |
| [15] | TAN Huihui, MAO Wei, YANG Zihan. Research Progress of Annexin A1 in Respiratory Diseases [J]. Chinese General Practice, 2025, 28(13): 1668-1673. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||